Tonix Pharmaceuticals Holding Corp. (TNXP)
13.24
-0.17
(-1.27%)
USD |
NASDAQ |
Mar 13, 16:00
13.29
+0.05
(+0.38%)
After-Hours: 20:00
Tonix Pharmaceuticals Debt to Equity Ratio : 0.0053 for Dec. 31, 2025
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Phio Pharmaceuticals Corp. | 0.00 |
| Jaguar Health, Inc. | 5.669 |
| MetaVia, Inc. | 0.0125 |
| Seastar Medical Holding Corp. | 0.00 |
| Jupiter Neurosciences, Inc. | 3.303 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 277.17M |
| Total Liabilities (Quarterly) | 32.02M |
| Shareholders Equity (Quarterly) | 245.15M |
| Current Ratio | 7.422 |
| Net Debt Paydown Yield | 1.28% |